{"id":2088,"date":"2025-07-31T15:37:00","date_gmt":"2025-07-31T15:37:00","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=2088"},"modified":"2026-02-22T01:02:29","modified_gmt":"2026-02-22T01:02:29","slug":"knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2025\/07\/31\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\/","title":{"rendered":"\u2018Knowing and Treating Kosaki\/Penttinen syndrome\u2019 international collaborative consortium: recommendations for follow-up, natural history and a real-life observational study about safety and efficacy profile of tyrosine kinase inhibitors (Contributed by Pr Laurence FAIVRE)"},"content":{"rendered":"

Kosaki and Penttinen syndromes are extremely rare genetic conditions that cause serious problems in multiple organs, including the brain, bones, and blood vessels. Since 2019, an international team of doctors and researchers has been working together to better understand and treat these conditions. They have created shared care guidelines, a global patient database, and are studying whether a type of medicine called tyrosine kinase inhibitors (TKIs) might help. So far, over 25 patients have been identified worldwide, and some have already received this treatment. This collaborative effort helps improve care and research where traditional clinical trials are not possible. (https:\/\/jmg.bmj.com\/content\/early\/2025\/07\/24\/jmg-2024-110600<\/a> )<\/p>\n","protected":false},"excerpt":{"rendered":"

Kosaki and Penttinen syndromes are extremely rare genetic conditions that cause serious problems in multiple organs, including the brain, bones, and blood vessels. Since 2019, an international team of doctors and researchers has been working together to better understand and treat these conditions. They have created shared care guidelines, a global patient database, and are […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2088","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\n\u2018Knowing and Treating Kosaki\/Penttinen syndrome\u2019 international collaborative consortium: recommendations for follow-up, natural history and a real-life observational study about safety and efficacy profile of tyrosine kinase inhibitors (Contributed by Pr Laurence FAIVRE) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2025\/07\/31\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u2018Knowing and Treating Kosaki\/Penttinen syndrome\u2019 international collaborative consortium: recommendations for follow-up, natural history and a real-life observational study about safety and efficacy profile of tyrosine kinase inhibitors (Contributed by Pr Laurence FAIVRE) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"Kosaki and Penttinen syndromes are extremely rare genetic conditions that cause serious problems in multiple organs, including the brain, bones, and blood vessels. Since 2019, an international team of doctors and researchers has been working together to better understand and treat these conditions. They have created shared care guidelines, a global patient database, and are [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2025\/07\/31\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-31T15:37:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-22T01:02:29+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/07\\\/31\\\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/07\\\/31\\\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"\u2018Knowing and Treating Kosaki\\\/Penttinen syndrome\u2019 international collaborative consortium: recommendations for follow-up, natural history and a real-life observational study about safety and efficacy profile of tyrosine kinase inhibitors (Contributed by Pr Laurence FAIVRE)\",\"datePublished\":\"2025-07-31T15:37:00+00:00\",\"dateModified\":\"2026-02-22T01:02:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/07\\\/31\\\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\\\/\"},\"wordCount\":138,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/07\\\/31\\\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/07\\\/31\\\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/07\\\/31\\\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\\\/\",\"name\":\"\u2018Knowing and Treating Kosaki\\\/Penttinen syndrome\u2019 international collaborative consortium: recommendations for follow-up, natural history and a real-life observational study about safety and efficacy profile of tyrosine kinase inhibitors (Contributed by Pr Laurence FAIVRE) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2025-07-31T15:37:00+00:00\",\"dateModified\":\"2026-02-22T01:02:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/07\\\/31\\\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/07\\\/31\\\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/07\\\/31\\\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u2018Knowing and Treating Kosaki\\\/Penttinen syndrome\u2019 international collaborative consortium: recommendations for follow-up, natural history and a real-life observational study about safety and efficacy profile of tyrosine kinase inhibitors (Contributed by Pr Laurence FAIVRE)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u2018Knowing and Treating Kosaki\/Penttinen syndrome\u2019 international collaborative consortium: recommendations for follow-up, natural history and a real-life observational study about safety and efficacy profile of tyrosine kinase inhibitors (Contributed by Pr Laurence FAIVRE) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2025\/07\/31\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\/","og_locale":"en_US","og_type":"article","og_title":"\u2018Knowing and Treating Kosaki\/Penttinen syndrome\u2019 international collaborative consortium: recommendations for follow-up, natural history and a real-life observational study about safety and efficacy profile of tyrosine kinase inhibitors (Contributed by Pr Laurence FAIVRE) - JMG Contact blog","og_description":"Kosaki and Penttinen syndromes are extremely rare genetic conditions that cause serious problems in multiple organs, including the brain, bones, and blood vessels. Since 2019, an international team of doctors and researchers has been working together to better understand and treat these conditions. They have created shared care guidelines, a global patient database, and are [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2025\/07\/31\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\/","og_site_name":"JMG Contact blog","article_published_time":"2025-07-31T15:37:00+00:00","article_modified_time":"2026-02-22T01:02:29+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/07\/31\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/07\/31\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"\u2018Knowing and Treating Kosaki\/Penttinen syndrome\u2019 international collaborative consortium: recommendations for follow-up, natural history and a real-life observational study about safety and efficacy profile of tyrosine kinase inhibitors (Contributed by Pr Laurence FAIVRE)","datePublished":"2025-07-31T15:37:00+00:00","dateModified":"2026-02-22T01:02:29+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/07\/31\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\/"},"wordCount":138,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2025\/07\/31\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/07\/31\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\/","url":"https:\/\/blogs.bmj.com\/jmg\/2025\/07\/31\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\/","name":"\u2018Knowing and Treating Kosaki\/Penttinen syndrome\u2019 international collaborative consortium: recommendations for follow-up, natural history and a real-life observational study about safety and efficacy profile of tyrosine kinase inhibitors (Contributed by Pr Laurence FAIVRE) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2025-07-31T15:37:00+00:00","dateModified":"2026-02-22T01:02:29+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/07\/31\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2025\/07\/31\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/07\/31\/knowing-and-treating-kosaki-penttinen-syndrome-international-collaborative-consortium-recommendations-for-follow-up-natural-history-and-a-real-life-observational-study-about-safety\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"\u2018Knowing and Treating Kosaki\/Penttinen syndrome\u2019 international collaborative consortium: recommendations for follow-up, natural history and a real-life observational study about safety and efficacy profile of tyrosine kinase inhibitors (Contributed by Pr Laurence FAIVRE)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/2088","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=2088"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/2088\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=2088"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=2088"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=2088"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}